Description
CIPROFLOZACIN 2MG 24X200 ML
First action · last action
2012-07-25 · 2012-07-25
Transactions
1
First transaction's obligation
$181,705
Base + all options value (sum of deltas)
$181,705
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
Parent IDV
V797P5037B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-07-25+$181,705= $181,705
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-07-25 | +$181,705 | $181,705 | CIPROFLOZACIN 2MG 24X200 ML |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PR1HCLM3FMW7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77026P0086 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $275,580 | FY2026 |
| 36F79724D0107 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| V797D40094 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2014 |
| VA797P13C0024 | NAC PHARMACEUTICALS 36P797 · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2013 |
| VA69D12J1551 | 69D-NETWORK CONTRACT OFFICE 12 · 6505 · DRUGS AND BIOLOGICALS | $3,846 | FY2012 |
| VA69D12J1486 | 69D-NETWORK CONTRACT OFFICE 12 · 6505 · DRUGS AND BIOLOGICALS | $110,561 | FY2012 |
Other recipients under 6505 from 69D-NETWORK CONTRACT OFFICE 12 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA69D16F2903 | CSL BEHRING L.L.C. | 69D-NETWORK CONTRACT OFFICE 12 | $5,443 | FY2016 |
| VA69D16F2824 | SANOFI VACCINES US INC. | 69D-NETWORK CONTRACT OFFICE 12 | $53,837 | FY2016 |
| VA69D16F2687 | SEQIRUS USA INC | 69D-NETWORK CONTRACT OFFICE 12 | $54,563 | FY2016 |
| VA69D16F2660 | SEQIRUS USA INC | 69D-NETWORK CONTRACT OFFICE 12 | $125,000 | FY2016 |
| VA69D16F2658 | SANOFI VACCINES US INC. | 69D-NETWORK CONTRACT OFFICE 12 | $141,675 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA69D12J1986_3600_V797P5037B_3600 · retrieved 2026-09-26.